ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ACHL Achilles Therapeutics PLC

0.92
-0.0197 (-2.10%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Achilles Therapeutics PLC ACHL NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0197 -2.10% 0.92 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9351 0.90 0.94 0.92 0.9397
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/5/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/5/202406:00GLOBEAchilles Therapeutics Announces Research Collaboration with..
17/5/202416:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/5/202416:00GLOBEAchilles Therapeutics Receives Nasdaq Deficiency Notice..
08/5/202406:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202406:00GLOBEAchilles Therapeutics Reports First Quarter 2024 Financial..
04/4/202405:45GLOBEAchilles Therapeutics Reports Fourth Quarter and Year-End..
04/4/202405:30GLOBEAchilles Therapeutics Provides Interim Phase I/IIa Update on..
05/2/202406:00GLOBEAchilles Therapeutics to Present at the 10th Annual..
01/2/202412:14EDGAR2Form 144 - Report of proposed sale of securities
18/12/202306:00GLOBEAchilles Therapeutics Announces Publication of Nature Cancer..
13/11/202315:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202315:30GLOBEAchilles Therapeutics Reports Third Quarter 2023 Financial..
01/11/202316:26EDGAR2Form 144 - Report of proposed sale of securities
22/9/202315:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/9/202315:30GLOBEAchilles Therapeutics Receives Nasdaq Deficiency Notice..
20/9/202307:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
17/8/202314:16EDGAR2Form 144 - Report of proposed sale of securities
04/8/202306:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/8/202306:00GLOBEAchilles Therapeutics Reports Second Quarter 2023 Financial..
29/6/202315:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/6/202307:00GLOBEAchilles Therapeutics to Present at Upcoming Conferences